Publications by authors named "Lluis Pages"

Claim this Profile
C
Correction: The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant spp.
Elena Fernández Álvaro, Phat Voong Vinh, Cristina de Cozar, David R Willé, Beatriz Urones, Lluis Ballell Pages

Elife· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases.
Montse Erra, Joan Taltavull, Francisco Javier Bernal, Juan Francisco Caturla, Marta Carrascal

J Med Chem· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphenyl Pyridazinone Derivatives as Inhaled PDE4 Inhibitors: Structural Biology and Structure-Activity Relationships.
Jordi Gràcia, Maria Antonia Buil, Jordi Castro, Peter Eichhorn, Manel Ferrer

J Med Chem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Marta Pérez-Garay, Beatriz Arteta, Esther Llop, Lara Cobler, Lluís Pagès

Int J Biochem Cell Biol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
Joan Taltavull, Jordi Serrat, Jordi Gràcia, Amadeu Gavaldà, Mònica Córdoba

Eur J Med Chem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of pyrido[3',2':4,5]thieno[3,2-d]pyrimidines as phosphodiesterase type 4 inhibitors.
Joan Taltavull, Jordi Serrat, Jordi Gràcia, Amadeu Gavaldà, Míriam Andrés

J Med Chem· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.
Marta Pérez-Garay, Beatriz Arteta, Lluís Pagès, Rafael de Llorens, Carme de Bolòs

PLoS One· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDE4 inhibitors: a review of current developments (2005 - 2009).
Lluís Pagès, Amadeu Gavaldà, Martin D Lehner

Expert Opin Ther Pat· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.
Josep Bonjoch, Faïza Diaba, Lluís Pagès, Daniel Pérez, Lidia Soca

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists.
Silvia Fonquerna, Montse Miralpeix, Lluís Pagès, Carles Puig, Arantxa Cardús

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.
Silvia Fonquerna, Montse Miralpeix, Lluís Pagès, Carles Puig, Arantxa Cardús

J Med Chem· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis